TD Cowen Cuts P3 Health Partners (NASDAQ:PIII) Price Target to $0.25

P3 Health Partners (NASDAQ:PIII) had its price target reduced by TD Cowen from $0.90 to $0.25 in a research report report published on Wednesday,Benzinga reports. They currently have a hold rating on the stock.

P3 Health Partners Price Performance

Shares of PIII opened at $0.21 on Wednesday. The company’s 50-day simple moving average is $0.37 and its 200-day simple moving average is $0.49. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.53 and a current ratio of 0.53. P3 Health Partners has a 1 year low of $0.19 and a 1 year high of $1.78. The stock has a market capitalization of $76.43 million, a PE ratio of -0.25 and a beta of 1.15.

Insider Buying and Selling at P3 Health Partners

In related news, major shareholder Pacific Founders Ugp I. Chicago purchased 80,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were bought at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the acquisition, the insider now directly owns 76,625,438 shares in the company, valued at $37,546,464.62. This trade represents a 0.10 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders acquired 400,000 shares of company stock valued at $205,600 in the last 90 days. Company insiders own 17.86% of the company’s stock.

Hedge Funds Weigh In On P3 Health Partners

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC increased its stake in shares of P3 Health Partners by 188.1% during the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after buying an additional 73,000 shares during the period. Sanders Morris Harris LLC grew its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after acquiring an additional 20,000 shares in the last quarter. Geode Capital Management LLC increased its position in shares of P3 Health Partners by 115.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after purchasing an additional 550,925 shares during the last quarter. Emfo LLC raised its holdings in shares of P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares in the last quarter. Finally, Armistice Capital LLC purchased a new stake in shares of P3 Health Partners during the 2nd quarter worth $3,557,000. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.